BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22793158)

  • 1. Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat"?
    Su S; Hassett DJ
    Expert Opin Ther Targets; 2012 Sep; 16(9):859-73. PubMed ID: 22793158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.
    Hassett DJ; Cuppoletti J; Trapnell B; Lymar SV; Rowe JJ; Yoon SS; Hilliard GM; Parvatiyar K; Kamani MC; Wozniak DJ; Hwang SH; McDermott TR; Ochsner UA
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1425-43. PubMed ID: 12458153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition in Biofilms between Cystic Fibrosis Isolates of
    Oluyombo O; Penfold CN; Diggle SP
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696740
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms.
    Matsui H; Wagner VE; Hill DB; Schwab UE; Rogers TD; Button B; Taylor RM; Superfine R; Rubinstein M; Iglewski BH; Boucher RC
    Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18131-6. PubMed ID: 17116883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.
    Yoon SS; Hennigan RF; Hilliard GM; Ochsner UA; Parvatiyar K; Kamani MC; Allen HL; DeKievit TR; Gardner PR; Schwab U; Rowe JJ; Iglewski BH; McDermott TR; Mason RP; Wozniak DJ; Hancock RE; Parsek MR; Noah TL; Boucher RC; Hassett DJ
    Dev Cell; 2002 Oct; 3(4):593-603. PubMed ID: 12408810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Discrepancy in the disk diffusion susceptibility test of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients after anaerobic preincubation and its potential clinical relevance].
    Cafini F; García-Rey C; Bas P; Gómez-Lus ML; Sánchez I; Vázquez S; Prieto J
    Rev Esp Quimioter; 2012 Dec; 25(4):269-73. PubMed ID: 23303259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.
    Schwab U; Abdullah LH; Perlmutt OS; Albert D; Davis CW; Arnold RR; Yankaskas JR; Gilligan P; Neubauer H; Randell SH; Boucher RC
    Infect Immun; 2014 Nov; 82(11):4729-45. PubMed ID: 25156735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection.
    Donnelly RF; McCarron PA; Cassidy CM; Elborn JS; Tunney MM
    J Control Release; 2007 Feb; 117(2):217-26. PubMed ID: 17196290
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.
    Jensen PØ; Kolpen M; Kragh KN; Kühl M
    APMIS; 2017 Apr; 125(4):276-288. PubMed ID: 28407427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
    Reid DW; Carroll V; O'May C; Champion A; Kirov SM
    Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    O'May CY; Reid DW; Kirov SM
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):373-80. PubMed ID: 17052266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G; McKevitt M; Elborn JS; Tunney MM
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.
    Tunney MM; Field TR; Moriarty TF; Patrick S; Doering G; Muhlebach MS; Wolfgang MC; Boucher R; Gilpin DF; McDowell A; Elborn JS
    Am J Respir Crit Care Med; 2008 May; 177(9):995-1001. PubMed ID: 18263800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.
    Kolpen M; Appeldorff CF; Brandt S; Mousavi N; Kragh KN; Aydogan S; Uppal HA; Bjarnsholt T; Ciofu O; Høiby N; Jensen PØ
    Pathog Dis; 2016 Feb; 74(1):ftv086. PubMed ID: 26458402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
    Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
    Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.